FILE:TMO/TMO-8K-20110809101302.txt.gz
EVENTS:	Financial Statements and Exhibits
TEXT:
ITEM: Financial Statements and Exhibits
Table of Contents
 
 
     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (General Instruction A.2. below):
see
      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
o
 
 
Table of Contents
We are filing this Amendment No. 1 to the Current Report on Form 8-K originally filed with the Securities and Exchange Commission on July 12, 2011 (the "Original 8-K") in order to add Exhibit 23.2. All other information contained in the Original 8-K, including pursuant to Item 8.01 and Item 9.01, is hereby incorporated by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
     See Exhibit Index attached hereto.
Table of Contents
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Table of Contents
 

Exhibit 23.2
We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-166176) of Thermo Fisher Scientific Inc. of our report dated February 24, 2011, except for the effects of Note 17 as to which the date is July 12, 2011, relating to the consolidated financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in the Current Report on Form 8-K filed July 12, 2011.
PricewaterhouseCoopers LLP Boston, Massachusetts August 9, 2011


